Est en marcha, en fase de reclutamiento, el estudio FOCUS (NCT03811561), que pretende incluir un total de 1.500 participantes, valorando el efecto del frmaco sobre la retinopata diabtica a largo plazo, en pacientes con DM2, con resultados esperables para 2027-2028
Some patients may require more frequent administration, but this should only be adjusted under clinical supervision after excluding other causes of persistent symptoms
Dysregulation is a hallmark of both chronic wounds and photoaged skin models
Studies were conducted to determine whether this dose could achieve greater weight reduction than the previous maximum maintenance dose of 2.4 mg
In brief, 10 weeks of once-weekly dosing of IcoSema (40 U icodec/0.114 mg semaglutide), icodec (40 U), or semaglutide (0.1072 mg) was simulated for each participant
Advocating for members to enable impactful experiences Using data like social determinants of health, plan sponsor design, member-designated preferences and medical data, we are proactive in the care of members, making sure they feel supported
